Machine learning-based approaches for distinguishing viral and bacterial pneumonia in paediatrics: A scoping review

Background and Objective: Pneumonia is the leading cause of hospitalisation and mortality among children under five, particularly in low-resource settings. Accurate differentiation between viral and bacterial pneumonia is essential for guiding appropriate treatment, yet it remains challenging due to overlapping clinical and radiographic features. Advances in machine learning (ML), particularly deep learning (DL), have shown promise in classifying pneumonia using chest X-ray (CXR) images. This scoping review summarises the evidence on ML techniques for classifying viral and bacterial pneumonia using CXR images in paediatric patients.Methods: This scoping review was conducted following the Joanna Briggs Institute methodology and the PRISMA-ScR guidelines. A comprehensive search was performed in PubMed, Embase, and Scopus to identify studies involving children (0–18 years) with pneumonia diagnosed through CXR, using ML models for binary or multiclass classification. Data extraction included ML models, dataset characteristics, and performance metrics.Results: A total of 35 studies, published between 2018 and 2025, were included in this review. Of these, 31 studies used the publicly available Kermany dataset, raising concerns about overfitting and limited generalisability to broader, real-world clinical populations. Most studies (n=33) used convolutional neural networks (CNNs) for pneumonia classification. While many models demonstrated promising performance, significant variability was observed due to differences in methodologies, dataset sizes, and validation strategies, complicating direct comparisons. For binary classification (viral vs bacterial pneumonia), a median accuracy of 92.3% (range: 80.8% to 97.9%) was reported. For multiclass classification (healthy, viral pneumonia, and bacterial pneumonia), the median accuracy was 91.8% (range: 76.8% to 99.7%).Conclusions: Current evidence is constrained by a predominant reliance on a single dataset and variability in methodologies, which limit the generalisability and clinical applicability of findings. To address these limitations, future research should focus on developing diverse and representative datasets while adhering to standardised reporting guidelines. Such efforts are essential to improve the reliability, reproducibility, and translational potential of machine learning models in clinical settings.